Form 8-K - Current report:
SEC Accession No. 0000950170-24-098032
Filing Date
2024-08-16
Accepted
2024-08-16 16:00:07
Documents
11
Period of Report
2024-08-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K cue-20240815.htm   iXBRL 8-K 55701
  Complete submission text file 0000950170-24-098032.txt   193052

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20240815.xsd EX-101.SCH 44883
13 EXTRACTED XBRL INSTANCE DOCUMENT cue-20240815_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 241216586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)